DuPont de Nemours (NYSE:DD – Get Free Report) had its price objective upped by investment analysts at Royal Bank of Canada from $102.00 to $104.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the basic materials company’s stock. Royal Bank of Canada’s target price would suggest a potential upside of 21.35% from the company’s current price.
A number of other research analysts have also recently issued reports on DD. Wells Fargo & Company lifted their price objective on DuPont de Nemours from $105.00 to $107.00 and gave the company an “overweight” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft upped their price target on shares of DuPont de Nemours from $92.00 to $98.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Citigroup decreased their target price on shares of DuPont de Nemours from $95.00 to $94.00 and set a “buy” rating for the company in a report on Friday, July 12th. Morgan Stanley increased their price target on shares of DuPont de Nemours from $88.00 to $94.00 and gave the company an “equal weight” rating in a report on Monday, October 21st. Finally, Barclays boosted their price objective on shares of DuPont de Nemours from $84.00 to $85.00 and gave the stock an “underweight” rating in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $95.42.
Get Our Latest Report on DuPont de Nemours
DuPont de Nemours Stock Up 1.6 %
DuPont de Nemours (NYSE:DD – Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The basic materials company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.03 by $0.15. DuPont de Nemours had a net margin of 5.30% and a return on equity of 6.31%. The business had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.20 billion. During the same quarter in the prior year, the company earned $0.92 earnings per share. The business’s revenue was up 4.4% compared to the same quarter last year. As a group, sell-side analysts forecast that DuPont de Nemours will post 3.76 earnings per share for the current year.
Institutional Trading of DuPont de Nemours
A number of institutional investors have recently bought and sold shares of DD. ESL Trust Services LLC purchased a new stake in shares of DuPont de Nemours in the first quarter worth approximately $26,000. Denver PWM LLC bought a new stake in shares of DuPont de Nemours during the second quarter worth $28,000. Strategic Investment Solutions Inc. IL purchased a new stake in shares of DuPont de Nemours during the second quarter valued at $27,000. Fortitude Family Office LLC increased its stake in DuPont de Nemours by 46.6% in the 2nd quarter. Fortitude Family Office LLC now owns 412 shares of the basic materials company’s stock worth $33,000 after buying an additional 131 shares during the period. Finally, Ashton Thomas Securities LLC bought a new stake in DuPont de Nemours during the 3rd quarter valued at about $38,000. 73.96% of the stock is currently owned by institutional investors.
DuPont de Nemours Company Profile
DuPont de Nemours, Inc provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits.
Recommended Stories
- Five stocks we like better than DuPont de Nemours
- Why Are Stock Sectors Important to Successful Investing?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- 3 Healthcare Dividend Stocks to Buy
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.